Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Bugianesi

Showing results (211-220 of 293) with videos related to

Pageof 30
Sort By:
Scientific Reports|March 8, 2019
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver DiseaseSerena Pelusi, Guido Baselli, Alessandro Pietrelli, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 6, 2023
Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver DiseaseChiara Rosso, Gian Paolo Caviglia, Giovanni Birolo, et al.
Hepatology (Baltimore, Md.)|October 11, 2019
qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic SteatohepatitisFeng Liu, George Boon-Bee Goh, Dina Tiniakos, et al.
Plos One|February 29, 2024
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical informationMatthew McTeer, Douglas Applegate, Peter Mesenbrink, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 18, 2021
Mistranslation Drives Alterations in Protein Levels and the Effects of a Synonymous Variant at the Fibroblast Growth Factor 21 LocusAli Bayoumi, Asmaa Elsayed, Shuanglin Han, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 16, 2025
ITA-MASLD: A national observational study to characterize the profile of patients with MASLD in specialistic care in ItalyElisabetta Bugianesi, Silvio Buscemi, Patrizia Burra, et al.
Hepatology (Baltimore, Md.)|November 19, 2011
Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver diseaseLars P Bechmann, Amalia Gastaldelli, Diana Vetter, et al.
The American Journal of Gastroenterology|May 27, 2020
Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver DiseaseRamy Younes, Olivier Govaere, Salvatore Petta, et al.
Nature Medicine|July 21, 2025
Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitisMaximilian Jara, Jenny Norlin, Mette Skalshøi Kjær, et al.
Scientific Reports|August 13, 2016
Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver diseaseRocío Gallego-Durán, Pablo Cerro-Salido, Emilio Gomez-Gonzalez, et al.
Pageof 30

Showing results (211-220 of 293) with videos related to

Sort By:
Pageof 30
Scientific Reports|March 8, 2019
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver DiseaseSerena Pelusi, Guido Baselli, Alessandro Pietrelli, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 6, 2023
Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver DiseaseChiara Rosso, Gian Paolo Caviglia, Giovanni Birolo, et al.
Hepatology (Baltimore, Md.)|October 11, 2019
qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic SteatohepatitisFeng Liu, George Boon-Bee Goh, Dina Tiniakos, et al.
Plos One|February 29, 2024
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical informationMatthew McTeer, Douglas Applegate, Peter Mesenbrink, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 18, 2021
Mistranslation Drives Alterations in Protein Levels and the Effects of a Synonymous Variant at the Fibroblast Growth Factor 21 LocusAli Bayoumi, Asmaa Elsayed, Shuanglin Han, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 16, 2025
ITA-MASLD: A national observational study to characterize the profile of patients with MASLD in specialistic care in ItalyElisabetta Bugianesi, Silvio Buscemi, Patrizia Burra, et al.
Hepatology (Baltimore, Md.)|November 19, 2011
Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver diseaseLars P Bechmann, Amalia Gastaldelli, Diana Vetter, et al.
The American Journal of Gastroenterology|May 27, 2020
Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver DiseaseRamy Younes, Olivier Govaere, Salvatore Petta, et al.
Nature Medicine|July 21, 2025
Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitisMaximilian Jara, Jenny Norlin, Mette Skalshøi Kjær, et al.
Scientific Reports|August 13, 2016
Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver diseaseRocío Gallego-Durán, Pablo Cerro-Salido, Emilio Gomez-Gonzalez, et al.
Pageof 30